Merck
  • Home
  • Search Results
  • Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.

Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.

Journal of microencapsulation (2014-06-26)
Amit Kumar De, Santanu Sana, Sriparna Datta, Arup Mukherjee
ABSTRACT

Abstract Context: Ursodeoxycholic acid (UDCA) exerts dose-dependent chemoprevention in colonic inflammation. Polycationic UDCA nanoparticles (UNPs) are envisaged for solubility enhancement and site directed drug delivery. The objective was to study the ameliorative efficacy of UNPs through localized delivery of the drug. UNPs were prepared through nanoprecipitation technique. Particle size, morphology, in vitro drug release and in vivo protective efficacy in inflammatory bowel disease (IBD) of these nanoparticles were studied. The average particle size was around 100 nm, and the average drug encapsulation was about 99%. In vitro drug release study shows optimal drug release in simulated colonic fluid. The lowering of tissue nitric oxide, malondialdehyde, myeloperoxidase and histology of the colon tissue supported the protective efficacy of the nanoparticles. This study presents the improved efficacy of UNPs in animal model of IBD due to complete release of drug at the desired site of action.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Trichloroacetic acid solution, 6.1 N (approx. 100% w/v)
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, ≥98%
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, for molecular biology, ≥99%
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, BioXtra, ≥99%
Sigma-Aldrich
Picrylsulfonic acid solution, 5 % (w/v) in H2O, BioReagent, suitable for determination of primary amines
Sigma-Aldrich
Trichloroacetic acid solution, 6.1 N
Sigma-Aldrich
Picrylsulfonic acid solution, 1 M in H2O
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, BioUltra, for molecular biology, ≥99.0% (AT)
Supelco
Hexadecyltrimethylammonium bromide, suitable for ion pair chromatography, LiChropur
Supelco
Hexadecyltrimethylammonium bromide, analytical standard
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, ≥96.0% (AT)
Sigma-Aldrich
Hexadecyltrimethylammonium bromide, Vetec, reagent grade, 96%
SAFC
Hexadecyltrimethylammonium bromide
Supelco
Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
o-Dianisidine dihydrochloride, tablet, 10 mg substrate per tablet
USP
Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
2-Thiobarbituric acid, ≥98%
Sigma-Aldrich
Trichloroacetic acid, BioXtra, ≥99.0%
Sigma-Aldrich
Trichloroacetic acid, ACS reagent, ≥99.0%
Sigma-Aldrich
Trichloroacetic acid, ≥99.0% (titration)
Sigma-Aldrich
Trichloroacetic acid, suitable for electrophoresis, suitable for fixing solution (for IEF and PAGE gels), ≥99%
Sigma-Aldrich
Hydrogen peroxide solution, tested according to Ph. Eur.
Sigma-Aldrich
Trichloroacetic acid, puriss., meets analytical specification of Ph. Eur., USP 21, 99-100.5% (calc. to the dried substance)
Sigma-Aldrich
Trichloroacetic acid, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Trichloroacetic acid, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Hydrogen peroxide solution, 34.5-36.5%
Sigma-Aldrich
Sulfanilamide, puriss. p.a., ≥99% (calc. to the dried substance)
Supelco
Hydrogen peroxide solution, ≥30%, for trace analysis
Sigma-Aldrich
o-Dianisidine dihydrochloride, Suitable for use in glucose determination
Supelco
Sulfanilamide, VETRANAL®, analytical standard